Hauffa, Berthold P <br/><br/>
Central laboratory reassessment of IGF-I, IGF-binding protein-3, and GH serum concentrations measured at local treatment centers in growth-impaired children: implications for the agreement between outpatient screening and the results of somatotropic axis functional testing.  [electronic resource] 

 -  European journal of endocrinology  Nov 2007 
 - 597-603 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1479-683X 
<br/><br/><label>Standard No.: </label>10.1530/EJE-07-0338  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ambulatory Care--standards<br/>Ambulatory Care Facilities--standards<br/>Child<br/>Clinical Laboratory Techniques--standards<br/>Female<br/>Growth Disorders--blood<br/>Human Growth Hormone--blood<br/>Humans<br/>Insulin-Like Growth Factor Binding Protein 3--blood<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>Mass Screening--standards<br/>Sensitivity and Specificity